by Jordana Choucair | Oct 20, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized a booster dose of Novavax’s COVID-19 vaccine. The booster was authorized for adults ages 18 and older who can’t take an mRNA vaccine or don’t have access to one, as well as for adults who would otherwise not receive a...
by Jordana Choucair | Oct 20, 2022 | Life Sciences
An FDA advisory panel recommended to pull Makena, a pre-term birth prevention drug, off the market. The panel said that the drug has not shown to be effective and exposes women to “serious risk.” The decision came after years of tension between the company, the...
by Jordana Choucair | Oct 19, 2022 | Life Sciences
The Kaiser Family Foundation released a brief examining how accessibility and cost of COVID-19 vaccines, treatments, and tests will change after the public health emergency (PHE) ends and such countermeasure efforts shift to the commercial market. The brief points out...
by Jordana Choucair | Oct 17, 2022 | Life Sciences
Starting today, Americans will be able to buy lower-cost hearing aids without a prescription or medical exam. The White House said that Walgreens Boots Alliance Inc. and Walmart Inc. locations are stocked with lower-cost hearing aids, while CVS Health Corp. will begin...
by Jordana Choucair | Oct 13, 2022 | Life Sciences
The Food and Drug Administration (FDA) announced it amended its emergency authorization of the bivalent COVID-19 boosters to include children between the ages of 5 and 11. The FDA’s decision grants Moderna’s request for authorization to administer its bivalent booster...
by Jordana Choucair | Oct 11, 2022 | Life Sciences
Walmart announced it is launching its Walmart Healthcare Research Institute in an effort to improve clinical trial diversity. The retailer will leverage its reach to help drug researchers connect to older adults, rural residents, women, and minority populations....
Recent Comments